Membranous nephropathy treatment standard doi.org/10.1093/ndt/...

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA doi.org/10.1093/ndt/...

When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice doi.org/10.1093/ndt/...

How should we best manage the consequences of nephron loss in IgAN? doi.org/10.1093/ndt/...

Disease modification in IgA nephropathy doi.org/10.1093/ndt/...

BK Polyomavirus-associated nephropathy – diagnostic and treatment standard 🆓 doi.org/10.1093/ndt/...

Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050 doi.org/10.1093/ndt/...

Cardiovascular involvement in ANCA-associated vasculitis doi.org/10.1093/ndt/...

Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds doi.org/10.1093/ndt/...

The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria doi.org/10.1093/ndt/...

Effectiveness and safety of finerenone in IgA nephropathy patients doi.org/10.1093/ndt/...

Management of monoclonal gammopathy of renal significance: treatment standard doi.org/10.1093/ndt/...

Kidney disease after hematopoietic stem cell transplant —treatment standard doi.org/10.1093/ndt/...

🤩Check out the new December issue of NDT! academic.oup.com/ndt/issue/40...

Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome. 📄: ow.ly/L9HK50XqqqT

Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents doi.org/10.1093/ndt/...

Trends in nephrology: from reducing proteinuria with steroids to curing glomerulonephritis doi.org/10.1093/ndt/...

Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox doi.org/10.1093/ndt/...

Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction doi.org/10.1093/ndt/...

C3G and Ig-MPGN: treatment standard doi.org/10.1093/ndt/...

👉Trends in nephrology: Cardiovascular Kidney-Metabolic syndrome 🆓 doi.org/10.1093/ndt/...

Global epidemiology of kidney cancer doi.org/10.1093/ndt/...

Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement doi.org/10.1093/ndt/...

Where is the eye of the storm of eGFR formulas? doi.org/10.1093/ndt/... The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe

Life support in hemodialysis emergencies—treatment standard More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

A novel system to continuously estimate intradialytic blood pressure in real time More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort More info:https://academic.oup.com/ndt/article/40/11/2091/8122110 @ndt-era.bsky.social, @hjanders.bsky.social

Interesting molecule - Troxerutin as an osmotic agent for PD academic.oup.com/ndt/advance-... in @ndt-era.bsky.social It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru... #PDSky #NephSky

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index doi.org/10.1093/ndt/...

Temporal trends in the treatment of relapsing minimal change podocytopathy — a binational cohort study doi.org/10.1093/ndt/...

Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry doi.org/10.1093/ndt/...

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases doi.org/10.1093/ndt/...

Treatment standard: CKD in the geriatric patient doi.org/10.1093/ndt/...

Complement activation in kidney transplantation doi.org/10.1093/ndt/...

Now open access in @ndt-era.bsky.social Prevalence of Strongyloides stercoralis in HD pts in Vienna 🧐Implementation of targeted screening for S. stercoralis should be considered in pre-KTX protocols in Europe. ▶️ academic.oup.com/ndt/article/...

Now online in @ndt-era.bsky.social Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI 🧐RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury. ▶️ academic.oup.com/ndt/article-...

Review on Renal amyloidosis More info: academic.oup.com/ndt/article-... @ndt-era.bsky.social, @hjanders.bsky.social

SGLT2 inhibitors in CKD: are they really effective in all patients? More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Now open access in @ndt-era.bsky.social How can we target the production of pathogenic IgA in IgAN? 🧐Drugs directed at mucosal B cells, inhibitors of APRIL and BAFF, and drugs that target IgA-producing plasma cells ▶️https://academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf185/8262262

Acute post-streptococcal glomerulonephritis in children—treatment standard More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Acute post-streptococcal glomerulonephritis in children —treatment standard doi.org/10.1093/ndt/...

Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds doi.org/10.1093/ndt/...

Association between exposure to air pollution and kidney function decline doi.org/10.1093/ndt/...

😍 Check out the new July issue of NDT! academic.oup.com/ndt/issue/40/7

Antibody-mediated rejection - treatment standard doi.org/10.1093/ndt/...

High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia doi.org/10.1093/ndt/...

Ongoing discussion about UACR or UPCR in GN captured in @ndt-era.bsky.social The use of UACR or UPCR for risk prediction in IgAN url:https://academic.oup.com/ndt/article-abstract/40/1/1/7702452 UACR predicts kidney events in IgAN url:https://academic.oup.com/ndt/article/40/3/465/7660570

Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA doi.org/10.1093/ndt/...

Mineralocorticoid receptor antagonism attenuates arteriovenous fistula stenosis by modulating the phenotype of vascular smooth muscle cells doi.org/10.1093/ndt/...

🤩Check out the new June issue of NDT! academic.oup.com/ndt/issue